Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-01-09
2007-01-09
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S236000
Reexamination Certificate
active
10789019
ABSTRACT:
Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticalsThe invention relates to diarylcycloalkyl derivatives and to their physiologically acceptable salts, racemates and physiologically functional derivatives.What is described are compounds of the formula I,in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparation. The compounds are suitable for the treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization disorders as well as of disorders in which insulin resistence is involved.
REFERENCES:
patent: 5411979 (1995-05-01), Hirose et al.
patent: 6221633 (2001-04-01), Ertl
patent: 6221897 (2001-04-01), Frick
patent: 6245744 (2001-06-01), Frick
patent: 6277831 (2001-08-01), Frick
patent: 6342512 (2002-01-01), Kirsch
patent: 6414002 (2002-07-01), Cheng et al.
patent: 6506781 (2003-01-01), Cobb et al.
patent: 6545009 (2003-04-01), Sugiyama et al.
patent: 6589969 (2003-07-01), Tajima et al.
patent: 6624185 (2003-09-01), Glombik et al.
patent: 2004/0198786 (2004-10-01), Gretzke et al.
patent: 2004/0209920 (2004-10-01), Stapper et al.
patent: 2004/0209931 (2004-10-01), Holla et al.
patent: 2004/0209932 (2004-10-01), Goerlitzer et al.
patent: 10142734 (2003-03-01), None
patent: 0 462 884 (2001-12-01), None
patent: 1 354 879 (2003-10-01), None
patent: WO 94/18183 (1994-08-01), None
patent: WO 94/18184 (1994-08-01), None
patent: WO 96/38428 (1996-12-01), None
patent: WO 97/26265 (1997-07-01), None
patent: WO 97/41097 (1997-11-01), None
patent: WO 98/08871 (1998-03-01), None
patent: WO 98/19998 (1998-05-01), None
patent: WO 99/03861 (1999-01-01), None
patent: WO 99/15525 (1999-04-01), None
patent: WO 99/61431 (1999-12-01), None
patent: WO 99/62871 (1999-12-01), None
patent: WO 99/62872 (1999-12-01), None
patent: WO 99/67278 (1999-12-01), None
patent: WO 99/67279 (1999-12-01), None
patent: WO 00/40569 (2000-07-01), None
patent: WO 00/63208 (2000-10-01), None
patent: WO 00/64888 (2000-11-01), None
patent: WO 00/66585 (2000-11-01), None
patent: WO 00/71549 (2000-11-01), None
patent: WO 200064876 (2000-11-01), None
patent: WO 00/78312 (2000-12-01), None
patent: WO 01/04146 (2001-01-01), None
patent: WO 01/09111 (2001-02-01), None
patent: WO 01/21602 (2001-03-01), None
patent: WO 01/40169 (2001-06-01), None
patent: WO 01/40171 (2001-06-01), None
patent: WO 01/72290 (2001-10-01), None
patent: WO 01/81327 (2001-11-01), None
patent: WO 01/83451 (2001-11-01), None
patent: WO 01/85695 (2001-11-01), None
patent: WO 01/91752 (2001-12-01), None
patent: WO 01/94300 (2001-12-01), None
patent: WO 02/38541 (2002-05-01), None
patent: WO 02/50027 (2002-06-01), None
patent: WO 02/051820 (2002-07-01), None
patent: WO 02/096864 (2002-12-01), None
patent: WO 2003020269 (2003-03-01), None
patent: WO 03/040174 (2003-05-01), None
patent: WO 03/084922 (2003-10-01), None
patent: WO 03/084923 (2003-10-01), None
patent: WO 03/104188 (2003-12-01), None
Stein, E., “Managing Dyslipidemia in the High-Risk Patient,” Am. J. Card., vol. 89(suppl.), pp. 50C-57C (2002), at p. 51C, col. 1, lines 15-16.
Asakawa A et al., Cocaine-Amphetamine-Regulated Transcript Influences Energy Metabolism Anxiety and Gastric Emptying in Mice, Hormone and Metabolic Reserch; vol. 33(9); 2001; pp. 554-558.
Berger Joel et al., The Mechanisms of Action of PPARs, Annul. Rev. Med.; vol. 53; 2002; pp. 409-435.
Fruchart Jean-Charles et al., PPARs, Metabolic Disease and Atherosclerosis, Pharmacological Research; vol. 44, No. 5; 2001' pp. 345-352.
Kersten Sander et al., Roles of PPARs in Health and Disease, Nature; vol. 405; May 25, 2000; pp. 421-424.
Kliewer Steven A et al., Peroxisome Proliferator-Activated Receptors: From Genes to Physiology, Recent Prog. Horm Res.; vol. 56; 2001; pp. 239-263.
Lee Daniel W et al., Leptin agonists as a potential approach to the treatment of obesity, Drugs of the Future; vol. 26(9); 2001; pp. 873-881.
Motojima Kiyoto, Peroxisome Proliferator-Activated Receptor (PPAR): Structure, Mechanisms of Activation and Diverse Functions, Cell Structure and Function; vol. 18; 1993; pp. 267-277.
Okada Hiroshi et al., Synthesis and Antitumor Activities of Prodrugs of Benzoylphenylureas, Chem. Pharm. Bull.; vol. 42(1); 1994; pp. 57-61.
Pineda Torra Ines et al., Peroxisome Proliferator-activated Receptors: from Transcriptional Control to Clinical Practice, Curr. Opin. Lipidol; vol. 12; 2001; pp. 245-254.
Pineda Torra Ines et al., Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging, Curr. Opin. Lipidol; vol. 10; 1999; pp. 151-159.
Stein E., Managing Dyslipidemia in the High-Risk Patient, Am. J. Card., vol. 89(suppl.), 2002, pp. 50C-57C.
Vidal-Puig A et al., Regulation of PPAR y Gene Expression by Nutrition and Obesity in Rodents, J. Clin. Invest.; vol. 97, No. 11, 1996; pp. 2553-2561.
Wilson Timothy M. et al., The PPARs: From Orphan Receptors to Drug Discovery, Journal of Medicinal Chemistry; vol. 43, No. 4; 2000; pp. 527-550.
Zunft H,. J. F. et al., Carob Pulp Preparation for Treatment of Hypercholesterolemia, Advances in Natural Therapy; vol. 18, No. 5; Sep.-Oct. 2001; pp. 230-236.
Falk Eugen
Glombik Heiner
Goerlitzer Jochen
Gretzke Dirk
Keil Stefanie
Anderson Rebecca L.
Kurys Barbara E.
McKane Joseph K.
Sanofi-Aventis Deutschland GmbH
LandOfFree
Diarylcycloalkyl derivatives, process for their preparation... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diarylcycloalkyl derivatives, process for their preparation..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diarylcycloalkyl derivatives, process for their preparation... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3822593